Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice

Neuroscience

Volumn 146, Issue 1, 2007, Pages 50-59

  Yan, Y ^a   Yamada, K ^a,b   Mizoguchi, H ^a   Noda, Y ^a   Nagai, T ^a,b   Nitta, A ^a   Nabeshima, T ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

dopamine D1 receptor antagonist; drug self administration; morphine; reinforcing properties; tPA knockout mice

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; MORPHINE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; KNOCKOUT MOUSE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; FOOD; MALE; MICE; MICE, KNOCKOUT; MORPHINE; NARCOTICS; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 34247492529     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.01.011     Document Type: Article

References (43)

1. Baranes D., Lederfein D., Huang Y.Y., Chen M., Bailey C.H., and Kandel E.R. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21 (1998) 813-825
2. Barrett A.C., Miller J.R., Dohrmann J.M., and Caine S.B. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 47 (2004) 256-273
3. Caine S.B., and Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270 (1994) 209-218
4. Chen Z.L., and Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91 (1997) 917-925
5. Ciccocioppo R., Martin-Fardon R., and Weiss F. Stimuli associated with a single cocaine experience elicit long-lasting cocaine-seeking. Nat Neurosci 7 (2004) 495-496
6. Corrigall W.A., and Coen K.M. Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol Biochem Behav 39 (1991) 799-802
7. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (1988) 5274-5278
8. Elmer G.I., Pieper J.O., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Failure of intravenous morphine to serve as an effective instrumental reinforcer in dopamine D2 receptor knock-out mice. J Neurosci 22 (2002) RC224
9. Frey U., Muller M., and Kuhl D. A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice. J Neurosci 16 (1996) 2057-2063
10. Gualandris A., Jones T.E., Strickland S., and Tsirka S.E. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 16 (1996) 2220-2225
11. Huang Y.Y., Bach M.E., Lipp H.P., Zhuo M., Wolfer D.P., Hawkins R.D., Schoonjans L., Kandel E.R., Godfraind J.M., Mulligan R., Collen D., and Carmeliet P. Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci U S A 93 (1996) 8699-8704
12. Ito M., Nagai T., Mizoguchi H., Fukakusa A., Nakanishi Y., Kamei H., Nabeshima T., Takuma K., and Yamada K. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue-plasminogen activator-plasmin system. J Neurochem (2006) in press
13. Junge C.E., Sugawara T., Mannaioni G., Alagarsamy S., Conn P.J., Brat D.J., Chan P.H., and Traynelis S.F. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci U S A 100 (2003) 13019-13024
14. Krystosek A., and Seeds N.W. Plasminogen activator release at the neuronal growth cone. Science 213 (1981) 1532-1534
15. Liu D., Cheng T., Guo H., Ferandez J.A., Griffin J.H., Song X.M., and Zlokovic B.V. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 10 (2004) 1379-1383
16. Lochner J.E., Honigman L.S., Grant W.F., Gessford S.K., Hansen A.B., Silverman M.A., and Scalettar B.A. Activity-dependent release of tissue plasminogen activator from the dendritic spines of hippocampal neurons revealed by live-cell imaging. J Neurobiol 66 (2006) 564-577
17. Madani R., Hulo S., Toni N., Madani H., Steimer T., Muller D., and Vassalli J.D. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J 18 (1999) 3007-3012
18. Mataga N., Nagai N., and Hensch T.K. Permissive proteolytic activity for visual cortical plasticity. Proc Natl Acad Sci U S A 99 (2002) 7717-7721
19. Moonen G., Grau-Wagemans M.P., and Selak I. Plasminogen activator-plasmin system and neuronal migration. Nature 298 (1982) 753-755
20. Nagai T., Yamada K., Yoshimura M., Ishikawa K., Miyamoto Y., Hashimoto K., Noda Y., Nitta A., and Nabeshima T. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci U S A 101 (2004) 3650-3655
21. Nagai T., Noda Y., Ishikawa K., Miyamoto Y., Yoshimura M., Ito M., Takayanagi M., Takuma K., Yamada K., and Nabeshima T. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. J Neurochem 92 (2005) 660-667
22. Nagai T., Kamei H., Ito M., Hashimoto K., Takuma K., Nabeshima T., and Yamada K. Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and dopamine-dependent hyperlocomotion, but not antinociceptive effect in mice. J Neurochem 93 (2005) 1272-1279
23. Nagai T., Ito M., Nakamichi N., Mizoguchi H., Kamei H., Fukakusa A., Nabeshima T., Takuma K., and Yamada K. The rewards of nicotine: regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1. J Neurosci 26 (2006) 12374-12383
24. Nicole O., Docagne F., Ali C., Margaill I., Carmeliet P., MacKenzie E.T., Vivien D., and Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7 (2001) 59-64
25. Olsen C.M., and Winder D.G. A method for single-session cocaine self-administration in the mouse. Psychopharmacology (Berl) (2006) in press
26. O'Neill M.F., and Shaw G. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology (Berl) 145 (1999) 237-250
27. O'Neill M.F., Heron-Maxwell C., Conway M.W., Monn J.A., and Ornstein P. Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice. Neuropharmacology 45 (2003) 565-574
28. Parmer R.J., Mahata M., Mahata S., Sebald M.T., O'Connor D.T., and Miles L.A. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. J Biol Chem 272 (1997) 1976-1982
29. Pawlak R., Magarinos A.M., Melchor J., McEwen B., and Strickland S. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci 6 (2003) 168-174
30. Pawlak R., Melchor J.P., Matys T., Skrzypiec A.E., and Strickland S. Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc Natl Acad Sci U S A 102 (2005) 443-448
31. Ripley T.L., Rocha B.A., Oglesby M.W., and Stephens D.N. Increased sensitivity to cocaine, and over-responding during cocaine self-administration in tPA knockout mice. Brain Res 826 (1999) 117-127
32. Roberts D.C., and Bennett S.A. Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 111 (1993) 215-218
33. Seeds N.W., Basham M.E., and Haffke S.P. Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci U S A 96 (1999) 14118-14123
34. Seeds N.W., Basham M.E., and Ferguson J.E. Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J Neurosci 23 (2003) 7368-7375
35. Self D.W. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 47 (2004) 242-255
36. Shin C.Y., Kundel M., and Wells D.G. Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation. J Neurosci 24 (2004) 9425-9433
37. Siao C.J., and Tsirka S.E. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 22 (2002) 3352-3358
38. Teesalu T., Kulla A., Simisker A., Siren V., Lawrence D.A., Asser T., and Vaheri A. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 92 (2004) 358-368
39. Ungless M.A., Whistler J.L., and Malenka R.C. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411 (2001) 583-587
40. Wang X., Lee S.R., Arai K., Lee S.R., Tsuji K., Rebeck G.W., and Lo E.H. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 9 (2003) 1313-1317
41. Yamada K., Nagai T., and Nabeshima T. Drug dependence, synaptic plasticity, and tissue plasminogen activator. J Pharmacol Sci 97 (2005) 157-161
42. Yan Y., Nitta A., Mizoguchi H., Yamada K., and Nabeshima T. Relapse of methamphetamine seeking behavior demonstrated by a reinstatement procedure involving self-administration. Behav Brain Res 168 (2006) 137-143
43. Zhuo M., Holtzman D.M., Li Y., Osaka H., DeMaro J., Jacquin M., and Bu G. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 20 (2000) 542-549